Meeting Overview - The second board meeting of Jianerkang Medical Technology Co., Ltd. was held on August 28, 2025, with all 9 directors present, complying with relevant laws and regulations [1][2]. Resolutions Passed - The board approved the full and summary reports for the 2025 semi-annual report, with a unanimous vote of 9 in favor [2]. - The board also approved the special report on the storage and use of raised funds for the first half of 2025, again with a unanimous vote of 9 in favor [2]. - A resolution was passed to change the company's registered capital, abolish the supervisory board, and amend the company's articles of association, with a unanimous vote of 9 in favor. This change aligns with the new Company Law effective from July 1, 2024 [3][4]. - The board approved the revision and formulation of several governance systems to enhance operational standards and governance structure, with a unanimous vote of 9 in favor [4]. - A proposal to convene the first extraordinary general meeting of shareholders in 2025 was also approved, with a unanimous vote of 9 in favor [5].
健尔康: 健尔康医疗科技股份有限公司第二届董事会第十四次会议决议公告